These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines. Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868 [TBL] [Abstract][Full Text] [Related]
4. Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells. Lee DH; Cheul Oh S; Giles AJ; Jung J; Gilbert MR; Park DM Oncotarget; 2017 Jun; 8(25):40233-40245. PubMed ID: 28410215 [TBL] [Abstract][Full Text] [Related]
5. Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect? El-Tohamy R; Elkholi I; Elsherbiny ME; Magdy M; Hammam O; Allalunis-Turner J; Emara M Oncol Rep; 2020 Mar; 43(3):975-985. PubMed ID: 32020230 [TBL] [Abstract][Full Text] [Related]
6. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids. Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999 [TBL] [Abstract][Full Text] [Related]
8. Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1α. Zhang Y; Liu Q; Wang F; Ling EA; Liu S; Wang L; Yang Y; Yao L; Chen X; Wang F; Shi W; Gao M; Hao A J Pineal Res; 2013 Sep; 55(2):121-30. PubMed ID: 23551342 [TBL] [Abstract][Full Text] [Related]
9. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049 [TBL] [Abstract][Full Text] [Related]
10. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells. Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041 [TBL] [Abstract][Full Text] [Related]
11. Anti-CD133 Antibody-Targeted Therapeutic Immunomagnetic Albumin Microbeads Loaded with Vincristine-Assisted to Enhance Anti-Glioblastoma Treatment. Wang X; Lu P; Zhu L; Qin L; Zhu Y; Yan G; Duan S; Guo Y Mol Pharm; 2019 Nov; 16(11):4582-4593. PubMed ID: 31573817 [TBL] [Abstract][Full Text] [Related]
12. Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma. Gaelzer MM; Santos MSD; Coelho BP; de Quadros AH; Simão F; Usach V; Guma FCR; Setton-Avruj P; Lenz G; Salbego CG Mol Neurobiol; 2017 Oct; 54(8):6261-6272. PubMed ID: 27714633 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. Maity A; Pore N; Lee J; Solomon D; O'Rourke DM Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786 [TBL] [Abstract][Full Text] [Related]
14. Resistance to hypoxia-induced, BNIP3-mediated cell death contributes to an increase in a CD133-positive cell population in human glioblastomas in vitro. Kahlert UD; Maciaczyk D; Dai F; Claus R; Firat E; Doostkam S; Bogiel T; Carro MS; Döbrössy M; Herold-Mende C; Niedermann G; Prinz M; Nikkhah G; Maciaczyk J J Neuropathol Exp Neurol; 2012 Dec; 71(12):1086-99. PubMed ID: 23147506 [TBL] [Abstract][Full Text] [Related]
15. Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells. Kucharzewska P; Christianson HC; Belting M PLoS One; 2015; 10(1):e0116740. PubMed ID: 25633823 [TBL] [Abstract][Full Text] [Related]
16. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment. Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570 [TBL] [Abstract][Full Text] [Related]
17. Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions. Lemaire L; Nel J; Franconi F; Bastiat G; Saulnier P PLoS One; 2016; 11(10):e0165479. PubMed ID: 27788227 [TBL] [Abstract][Full Text] [Related]
19. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Hendriksen EM; Span PN; Schuuring J; Peters JP; Sweep FC; van der Kogel AJ; Bussink J Microvasc Res; 2009 Mar; 77(2):96-103. PubMed ID: 19118564 [TBL] [Abstract][Full Text] [Related]
20. Involvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells. Wan YY; Zhang JF; Yang ZJ; Jiang LP; Wei YF; Lai QN; Wang JB; Xin HB; Han XJ Oncol Rep; 2014 Aug; 32(2):619-26. PubMed ID: 24899388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]